<DOC>
	<DOCNO>NCT02101710</DOCNO>
	<brief_summary>This study evaluate bioequivalence Elantan SR 60 mg compare Imdur SR 60 mg sixty healthy Korean male subject .</brief_summary>
	<brief_title>Pharmacokinetic Properties Isosorbide-5-mononitrate Under Fasting Fed Condition Healthy Male Subjects</brief_title>
	<detailed_description>This study evaluate bioequivalence Elantan SR 60 mg compare Imdur SR 60 mg sixty healthy Korean male subject . Thirty subject participate fast state thirty subject feed state . Elantan SR 60 mg Imdur 60 mg two formulation Isosorbide 5-mononitrate .</detailed_description>
	<mesh_term>Isosorbide-5-mononitrate</mesh_term>
	<mesh_term>Isosorbide Dinitrate</mesh_term>
	<mesh_term>Isosorbide</mesh_term>
	<criteria>An Institutional Review Board ( IRB ) /Independent Ethics Committee ( IEC ) approve write informed consent sign date subject Subject consider reliable capable adhere protocol ( eg , able understand complete schedule study assessment ) , visit schedule medication intake accord judgment investigator Subject healthy Korean male , 1955 year age Subject normal body weight determine body mass index 18.5 kg/m^2 24.9 kg/m^2 Sitting blood pressure within follow range : SBP ( Systolic Blood Pressure ) , 90139 mmHg ; DBP ( Diastolic Blood Pressure ) , 5089 mmHg Subject abnormal symptom physical examination without congenital chronic disease Subject previously participate study subject previously assign treatment study medication investigation study Subject participate another study investigational medication ( medical device ) within last 90 day currently participate another study investigational medication ( medical device ) Subject history chronic alcohol drug abuse within last 6 month Subject medical psychiatric condition , opinion investigator , could jeopardize would compromise subject 's ability participate study Subject know hypersensitivity nitrate component investigational medicinal product reference drug state protocol Subject history present condition cardiovascular disease , like acute circulatory failure ( shock , vascular collapse ) , low BP , acute myocardial infarction low filling pressure , arrhythmia , leave heart failure low filling pressure , hypotension , acute attack angina , constrictive pericarditis , hypertrophic obstructive cardiomyopathy , cardiac tamponade , aortic valve and/or mitral valve stenosis Subject history present condition severe anemia , head trauma , cerebral haemorrhage , hematopenia , severe cerebrovascular insufficiency , glaucoma , gastrointestinal disorder , neurological abnormality , hepatic disorder , renal , pulmonary metabolic disease Subject use phosphodiesterase 5 inhibitor ( sildenafil , tadalafil vardenafil ) Symptomatic asymptomatic orthostatic hypotension screening define 20 mmHg decrease systolic pressure , 10 mmHg decrease diastolic pressure 1 3 minute stand arm relax side ( time zero begin subject upright ) . 5 minute supine rest use baseline Subject family personal history abnormal bleeding Subject clinically relevant range value hematology clinical chemistry parameter . However , agreement sponsor , Investigator may include subject value outside accepted range , his/her opinion , value clinical significance justification give Subject clinically relevant abnormality physical examination Subject make blood donation comparable blood loss ( &gt; 400ml ) within last 3 month prior first day dose Any clinical condition opinion Investigator would make subject unsuitable study Patients rare hereditary problem galactose intolerance , Lapp lactase deficiency glucosegalactose malabsorption due presence lactose Subjects take drug product enzyme inducer , barbiturate , inhibitor ; drink excessive alcohol within one month prior initiation BE ( Bioequivalence ) study Subjects take drug product could influence result BE study within 10 day initiation BE study</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Bioequivalence</keyword>
	<keyword>Isosorbide 5-mononitrate</keyword>
	<keyword>Elantan</keyword>
	<keyword>Imdur</keyword>
	<keyword>Korean</keyword>
	<keyword>Healthy</keyword>
</DOC>